£107.98

Springer The Epothilones: An Outstanding Family of Anti-Tumor Agents: From Soil to the Clinic: 90 (Fortschritte der Chemie organischer Naturstoffe Progress in the Chemistry of Organic Natural Products, 90)

Price data checked 5 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 86 days • 86 data points (No recent data available)

Historical
Generating forecast...
£107.98 £107.38 £107.51 £107.64 £107.77 £107.90 £108.04 06 April 2026 27 April 2026 18 May 2026 08 June 2026 30 June 2026

Price Distribution

Price distribution over 86 days • 2 price levels

Days at Price
Current Price
32 days 54 days · current 0 14 27 41 54 £107 £108 Days at Price

Price Analysis

Most common price: £108 (54 days, 62.8%)

Price range: £107 - £108

Price levels: 2 different prices over 86 days

Description

Epothilones have received unusual attention over the past ten years. They are novel antitumor drugs which very much like their predecessor paclitaxel (Taxol) act via microtubule stabilization. In comparison to paclitaxel and a number of alternative drugs with a similar mode of bioaction (e.g. laulimalide, eleutherobin, peluroside, discodermolide) the epothilones have significant advantages, above all very high activity in the nanomolar range and low susceptibility towards multidrug resistance. Epothilone B and several derivatives thereof are in phase I-III clinical trials; one of them (ixabepilone, BMS) is already on the market, others are supposed to appear on the market in the near future. All naturally occurring epothilones have been isolated from Sorangium cellulosum; their antitumor action is traced back to the stabilization of microtubules. In consequence, the formation of the mitototic spindle is prohibited and the cell undergoes apoptosis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
19 October 2010
Listed Since
22 November 2010

Barcode

No barcode data available

Similar Products You Might Like

Pharmacotherapeutic Botanicals for Cancer Chemoprevention
76% match

Pharmacotherapeutic Botanicals for Cancer Chemoprevention

Springer

£100.08 30 May 2026
Anticancer plants: Properties and Application: Volume 1
76% match

Anticancer plants: Properties and Application: Volume 1

Springer

£108.92 06 Jun 2026
Apoptosome: An up-and-coming therapeutical tool
76% match

Apoptosome: An up-and-coming therapeutical tool

Springer

£110.02 30 May 2026
Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance: From Basic to Clinical Research
76% match

Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance: From Basic to Clinical Research

Springer

£113.76 18 May 2026
New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)
75% match

New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)

Springer

£77.83 31 May 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
75% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£74.87 24 May 2026
Advances in Endophytic Research
75% match

Advances in Endophytic Research

Springer

£147.96 28 May 2026
Novel Apoptotic Regulators in Carcinogenesis
75% match

Novel Apoptotic Regulators in Carcinogenesis

Springer

£124.17 12 Jun 2026
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
75% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 31 May 2026
Molecular Targeted Therapy of Lung Cancer
75% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.70 06 Jun 2026
Pancratistatin: An Apoptosis Inducer: Applications to Cancer Therapy
75% match

Pancratistatin: An Apoptosis Inducer: Applications to Cancer Therapy

LAP Lambert Academic Publishing

£42.00 30 Jun 2026
Emerging Concepts of Tumor Exosome–Mediated Cell-Cell Communication
75% match

Emerging Concepts of Tumor Exosome–Mediated Cell-Cell Communication

Springer

£103.26 03 Jul 2026
Advances in Cancer Stem Cell Biology
74% match

Advances in Cancer Stem Cell Biology

Springer

£95.45 25 Jun 2026
The Kinetochore:: From Molecular Discoveries to Cancer Therapy
74% match

The Kinetochore:: From Molecular Discoveries to Cancer Therapy

Springer

£84.99 01 Jul 2026
Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)
74% match

Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)

Humana

£107.98 25 May 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
74% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 05 Jun 2026
Metronomic Chemotherapy: Pharmacology and Clinical Applications
74% match

Metronomic Chemotherapy: Pharmacology and Clinical Applications

Springer

£81.78 27 May 2026
Advances in Cancer Stem Cell Biology
74% match

Advances in Cancer Stem Cell Biology

Springer

£107.98 01 Jun 2026
Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy: 10 (Progress in Clinical Biochemistry and Medicine, 10)
74% match

Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy: 10 (Progress in Clinical Biochemistry and Medicine, 10)

Springer

£109.06 03 Jun 2026
Organ Directed Toxicities of Anticancer Drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer ... 4–6, 1987: 53 (Developments in Oncology, 53)
74% match

Organ Directed Toxicities of Anticancer Drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer ... 4–6, 1987: 53 (Developments in Oncology, 53)

Springer

£107.98 03 Jun 2026
Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II): Thiol “Switch-on” Fluorescent Probes, Thioredoxin Reductase ... Reticulum Targeting Agents (Springer Theses)
74% match

Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II): Thiol “Switch-on” Fluorescent Probes, Thioredoxin Reductase ... Reticulum Targeting Agents (Springer Theses)

Springer

£74.27 02 Jun 2026
Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)
74% match

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)

Springer

£74.57 02 Jun 2026
Apoptosis in Carcinogenesis and Chemotherapy: Apoptosis in cancer
74% match

Apoptosis in Carcinogenesis and Chemotherapy: Apoptosis in cancer

Springer

£144.14 19 May 2026
Targeted Drug Strategies for Cancer and Inflammation
74% match

Targeted Drug Strategies for Cancer and Inflammation

Springer

£84.32 30 Jun 2026